1.0UDIBIhttps://udibi.com.mx/en/rich600338<blockquote class="wp-embedded-content" data-secret="dmYd9i60Jp"><a href="https://udibi.com.mx/en/anti-cd22/">Anti-CD22</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://udibi.com.mx/en/anti-cd22/embed/#?secret=dmYd9i60Jp" width="600" height="338" title="“Anti-CD22” — UDIBI" data-secret="dmYd9i60Jp" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://udibi.com.mx/wp-includes/js/wp-embed.min.js /* ]]> */ </script> [vc_row][vc_column][vc_custom_heading text=”Anti-CD22″ font_container=”tag:h2|font_size:35|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text] Acute lymphoblastic leukemia (ALL) is a hematologic malignancy with abnormal production of immature blasts in the bone marrow with infiltration towards spleen, liver, lymph nodes, and CNS. It is commonly diagnosed in pediatric oncology and its treatment is based on chemotherapy; however, in patients with relapses, the use of cell-based or antibody-based immunotherapy has been useful. […]